Suzhou Nanomed and Nanomed Devices Wins the Silver Award for Its Intradermal Drug Delivery Device
Published: Nov 12, 2010
SUZHOU, CHINA--(Marketwire - November 12, 2010) - Suzhou Natong with its US partner Nanomed Devices, Inc. announced yesterday that they won the Silver Prize of the Asian Innovation Awards 2010 at the Biobay Investor Forum. The award was sponsored by The Wall Street Journal Asia in partnership with Credit Suisse AG.
Suzhou Natong Bionanotechnology received the Silver Award for creating a drug-delivery device that uses a set of needles smaller than human hairs for painless injections.
This year the Asian Innovation Awards attracted nearly 300 entries from 13 countries and territories throughout Asia Pacific. They were judged on their ability to enrich and improve the quality of life and productivity across the region.
Speaking at the gala event, Marcel Kreis, head of private banking, Asia Pacific at Credit Suisse, said, "I would like to congratulate this year's winners for their remarkable effort in coming up with an innovative idea and turning it into a reality that helps enrich and improve the quality of life and productivity among communities in Asia Pacific and around the world. We will continue to support the Asian Innovation Awards in the hope of creating inspiration to others in making this world a better place to live in, working for the common good and bringing about lasting change."
"The need to innovate is a crucial part of good business practice. The ability to develop creative ideas and see new opportunities to fruition brings companies renewed growth and investment for the future," said Almar Latour, The Wall Street Journal's editor in chief in Asia. "We received a record number of very high-caliber entries in this year's awards and we're proud to have provided a platform to showcase their creative ideas and innovative concepts."
Dr. Bai Xu, Suzhou Natong Bionanotechnology's CEO, said at the ceremony, "Winning the prize is the recognition of our company's innovation and potentials. It will help us to build up the reputation and good image of the company and is significant to our future."
About Suzhou Natong Bionanotechnology Co.
Suzhou Natong, with US partner Nanomed Devices Inc., focuses on developing innovative medical products for drug delivery. Its FMA™ Intradermal Drug Delivery Technology is a novel drug delivery platform using nanoscale MEMS (micro-electro-mechanical) technology. The company has six issued patents, including one in the US and has launched acne product in China.
Company website: www.nanomed-devices.com/en
About The Wall Street Journal Asia
The Wall Street Journal Asia is the leader in global business news for Asia. Since 1976, it has provided indispensable news and analysis of regional and global business developments for an influential pan-Asian audience of corporate and government decision-makers. The Wall Street Journal Asia has been voted the most "important business reading" among international daily newspapers in Asia in every ABRS/BE:ASIA study since the survey's inception in 1985.
Edited and published in Hong Kong, The Wall Street Journal Asia is printed in eleven Asian cities-Bangkok, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, New Delhi, Seoul, Singapore, Taipei and Tokyo-and distributed throughout the Asia Pacific region. More than 75% of its subscribers are Asian.
The Wall Street Journal's Web site for Asia is at www.asia.WSJ.com and homepage for India is at www.india.WSJ.com. The Wall Street Journal is also published online in Japanese at www.japan.WSJ.com and in Chinese at www.chinese.WSJ.com.
Credit Suisse AG
Credit Suisse AG is one of the world's leading financial services providers and is part of the Credit Suisse group of companies (referred to here as 'Credit Suisse'). As an integrated bank, Credit Suisse offers clients its combined expertise in the areas of private banking, investment banking and asset management. Credit Suisse provides advisory services, comprehensive solutions and innovative products to companies, institutional clients and high-net-worth private clients globally, as well as to retail clients in Switzerland. Credit Suisse is headquartered in Zurich and operates in over 50 countries worldwide. The group employs approximately 50,500 people. The registered shares (CSGN) of Credit Suisse's parent company, Credit Suisse Group AG, are listed in Switzerland and, in the form of American Depositary Shares (CS), in New York. Further information about Credit Suisse can be found at www.credit-suisse.com.
Nanomed Devices, Inc.